What every parent should know about pfas cancer risk
PFAS cancer risk refers to the elevated probability of developing certain cancers - particularly kidney, testicular, thyroid, bladder, and breast cancer - from exposure to per- and polyfluoroalkyl substances. In December 2023, the WHO's International Agency for Research on Cancer (IARC) classified PFOA as a confirmed Group 1 human carcinogen and PFOS as a possible Group 2B carcinogen. The strongest evidence comes from the C8 Health Project, which tracked 69,000+ people near DuPont's contaminated Parkersburg, WV plant, and from multiple independent cohort studies. PFAS-contaminated drinking water, older nonstick cookware, and occupational exposures are the primary risk pathways for families.
We score every product the same way and never accept brand payment. We may earn a commission from some links, which never changes a score. How we stay independent.
Quick facts
Get the research before you buy
New picks and safety research, no spam, no sponsors.
The claim: My cookware is PFOA-free so I don't need to worry about PFAS cancer risk
The reality: PFOA-free is essentially a universal claim on all post-2015 cookware - it describes a chemical that was phased out of US manufacturing a decade ago. It says nothing about GenX (PFOA's replacement), other PFAS, whether the pan contains PTFE, or your drinking water - which is actually the most significant PFAS cancer risk pathway for most families. The cancer risk from PFAS is primarily a drinking water and older cookware story, not a modern PFOA-free-labeled cookware story.
If you've been paying attention to product safety research over the last few years, you've probably seen the headlines: PFAS chemicals cause cancer. But the details matter enormously here - which PFAS, which cancers, at what exposures, for whom, and through what mechanisms. The research is real and the risks are significant, but the picture is more precise than most media coverage suggests.
Let me walk you through what we actually know.
In November 2023, the International Agency for Research on Cancer (IARC) - the WHO's cancer research arm and the global gold standard for carcinogenicity evaluation - published Volume 135 of its Monographs series, which evaluated PFOA and PFOS for carcinogenicity.
The findings were significant:
The IARC working group based its PFOA determination on several lines of converging evidence: limited but meaningful data in humans for kidney and testicular cancer, sufficient evidence in experimental animals across multiple tumor types, and strong mechanistic evidence that PFOA exhibits key characteristics of carcinogens in exposed humans - including epigenetic alterations and immunosuppression.
This is not the first time PFOA has been linked to cancer. But the Group 1 classification represents the scientific community's consensus that the causal evidence is now strong enough to move from "probable" to "confirmed."
Most of what we understand about PFOA and cancer in real-world human populations comes from a single extraordinary data source: the C8 Health Project.
The project originated from attorney Rob Bilott's 1999 lawsuit against DuPont, filed on behalf of a farmer whose cattle were dying near the company's Washington Works plant in Parkersburg, West Virginia. The plant had been manufacturing PTFE (Teflon) using PFOA as a processing aid since the early 1950s - and had been depositing PFOA waste in ways that contaminated drinking water for surrounding communities in both West Virginia and Ohio.
The 2004 settlement created the C8 Science Panel - an independent team of epidemiologists tasked with enrolling 69,000+ area residents, measuring their PFOA serum levels, and tracking their health outcomes for years. This is the largest prospective community health study ever conducted on a single chemical.
Between 2011 and 2012, the C8 Science Panel delivered its findings. PFOA was found to have a "probable link" with six health outcomes:
Those "probable link" findings - which carried legal weight in the DuPont litigation and ultimately led to more than $671 million in settlements to approximately 3,500 plaintiffs - have since been reinforced by multiple independent cohort studies and were central to IARC's 2023 Group 1 determination.
Kidney cancer has the strongest and most consistent evidence linking it to PFOA exposure. The C8 Science Panel found a probable link between PFOA and kidney cancer in its Parkersburg cohort. Independent data from the NCI's PLCO Cancer Screening Trial - which followed a population with typical US exposure levels, not just industrial hotspot residents - found a relative risk of approximately 1.9 for kidney cancer with higher serum PFOA.
A 2024 systematic review and meta-analysis published in PMC found that PFAS exposure was associated with elevated kidney cancer risk, with the evidence particularly strong for PFOA and PFNA. County-level analysis of US cancer incidence data from 2016 to 2021 found that PFNA exposure was associated with kidney cancer incidence rate ratios of 1.07 (95% CI 1.03 to 1.11). These are population-level effects - the absolute risk elevation for any individual is modest, but the exposed population is enormous.
Testicular cancer is the other cancer with the most compelling evidence. The C8 Science Panel found a probable link in the Parkersburg cohort. Studies of military personnel with AFFF (aqueous film-forming foam) firefighting exposure - which delivers extremely high PFOS doses - have found elevated testicular cancer rates consistent with PFAS toxicity.
The biological mechanism is particularly plausible for testicular cancer: PFAS accumulates in testicular tissue at concentrations several times higher than blood serum levels, and these chemicals interfere with sex hormone signaling in Leydig cells. PFOS disruption of testosterone synthesis provides a coherent pathway from exposure to tumor development.
A 2023 study published in The Lancet eBioMedicine conducted a meta-analysis of PFAS exposure and thyroid cancer risk across multiple human cohorts. The findings showed a 56% increased risk of thyroid cancer in individuals with higher PFAS exposure. The mechanism here is structural: PFOA closely resembles thyroid hormones and competes for the thyroid hormone transport proteins in blood (particularly thyroglobulin), disrupting the entire thyroid signaling axis.
Thyroid cancer has been among the fastest-rising cancer types in the US over the past three decades, during a period of peak PFAS exposure in the general population. Whether that ecological correlation reflects a causal relationship is still being investigated, but the biological plausibility is high.
A 2024 county-level analysis published in the Journal of Exposure Science and Environmental Epidemiology found that counties with detectable PFAS compounds in drinking water showed elevated bladder cancer incidence. Incidence rate ratios ranged from 1.03 to 1.08 for specific PFAS compounds including PFHxS, PFOS, PFNA, PFHpA, and PFOA. A 2024 American Urological Association study (PD24-09) found associations between PFAS exposure and urological cancer risk that included bladder cancer.
The evidence for bladder cancer is newer and less robust than for kidney and testicular cancer, but it is accumulating. PFAS are excreted through the kidneys and concentrated in urine, which means the bladder epithelium receives sustained, concentrated PFAS contact - a plausible biological basis for the association.
The breast cancer evidence is emerging. A nested case-control study among French women found a positive association between pre-diagnostic serum PFOS concentrations and postmenopausal breast cancer, particularly for hormone receptor-positive tumor subtypes. The hormone receptor-positive specificity is mechanistically important: PFAS act as endocrine disruptors that mimic estrogen, and hormone-receptor-positive breast cancers are precisely those driven by estrogen signaling. The evidence is not yet sufficient for a definitive classification, but the endocrine disruption pathway makes breast cancer a plausible PFAS risk.
A January 2025 study published in the Journal of Exposure Science and Environmental Epidemiology estimated that PFAS contamination in drinking water contributes to more than 6,800 new cancer cases per year in the United States alone. That estimate covers only drinking water exposure - it does not include exposure through cookware, food packaging, or occupational routes. It underscores that even modest per-person risk elevation, multiplied across a population where nearly half of Americans have detectable PFAS in tap water, produces a substantial public health burden.
Understanding why PFAS are carcinogenic matters not just for science but for understanding which exposures are highest priority to reduce. The IARC working group and subsequent mechanistic research have identified several convergent pathways:
PFAS - particularly PFOA and PFOS - increase fatty acid oxidation in cells, which generates reactive oxygen species (ROS). These unstable molecules damage DNA, lipids, and proteins. Increased oxidative stress is one of the most fundamental drivers of carcinogenesis, creating the cellular environment that allows mutations to accumulate unchecked. Multiple in vitro and animal studies have documented PFAS-induced oxidative stress across liver, kidney, and immune cells.
PFAS are immunotoxic - they suppress the immune system's ability to identify and destroy early cancer cells. The landmark Grandjean et al. study (JAMA, 2012) documented that each doubling of serum PFOS in children at age 5 was associated with a 49% reduction in diphtheria vaccine antibody response. The National Toxicology Program concluded that PFOA and PFOS are "presumed immune hazards in humans."
For cancer specifically, this matters because the immune system conducts continuous surveillance for malignant cells. Suppress that surveillance - which PFAS do through multiple mechanisms including inhibition of natural killer cell activity and T-cell function - and nascent tumor cells that would otherwise be eliminated gain time to establish themselves.
PFAS have been linked to both hyper- and hypomethylation of DNA - essentially, they can silence genes that suppress tumors (turning off protective mechanisms) and activate genes that promote cell proliferation. IARC specifically cited epigenetic alterations as key evidence in the PFOA Group 1 determination. These changes can be persistent, propagate through cell division, and in some cases may be transgenerational.
PFOA activates peroxisome proliferator-activated receptor alpha (PPAR-alpha) in the liver and kidney. PPAR-alpha activation drives cell proliferation and suppresses apoptosis (programmed cell death) - two hallmarks of cancer. This receptor-mediated pathway is most relevant for liver and kidney cancer. Whether PPAR-alpha effects translate directly from rodent studies to humans is debated, but the pathway's relevance to human kidney cancer is supported by epidemiological data.
PFAS structurally mimic thyroid hormones and compete for estrogen signaling pathways, binding to estrogen receptors and altering hormone-dependent gene expression. This disruption is most relevant to thyroid cancer (structural mimicry) and hormone-receptor-positive breast cancer (estrogen pathway). It also affects sex hormone synthesis in Leydig cells, providing a plausible pathway to testicular cancer.
Nearly everyone in the US has PFAS in their blood. CDC biomonitoring data from NHANES surveys conducted since 1999 shows that PFOA and PFOS have been detected in the vast majority of Americans tested, though blood levels have declined significantly since peak manufacturing years - PFOS blood levels fell more than 85% and PFOA levels more than 70% from 1999-2000 to 2018-2019 as production was phased down.
But certain groups carry substantially higher body burdens and face meaningfully greater cancer risk:
Communities near contaminated drinking water sites. Residents near former PFOA manufacturing plants - the DuPont/Chemours facilities in Parkersburg, WV and Fayetteville, NC are the most studied - faced exposures orders of magnitude above the national average. People living near military bases where AFFF was used for training and emergency response, or near airports with heavy AFFF use history, face similar contamination patterns. The Department of Defense has identified 723 installations where PFAS may have been used or released.
Military and civilian firefighters. Firefighters who used AFFF foam during training or emergency response received extremely high PFAS doses - AFFF is essentially concentrated PFOS. Studies of Air Force personnel with AFFF exposure have found elevated PFOS blood levels and associations with testicular cancer. NIOSH has ongoing studies of cancer rates in firefighter populations with PFAS exposure histories.
Private well users near industrial or military sites. EPA's April 2024 drinking water MCLs apply only to public water systems. Private well users have no regulatory protection. In contaminated areas, private well PFAS concentrations can be hundreds of times above the EPA's 4 ppt MCL.
Workers at PFAS manufacturing facilities, semiconductor plants using PFAS processing chemicals, and industries using AFFF have faced the highest occupational exposures. The original DuPont Washington Works workers showed elevated kidney and testicular cancer rates that were among the first signals in the epidemiological record.
The most actionable PFAS cancer risk guidance for cookware and air fryers comes down to one date: 2015. Nonstick cookware and air fryer baskets with PTFE coatings manufactured before 2013-2015 were made using PFOA - now a confirmed Group 1 human carcinogen. Scratched, chipped, or worn coatings on pre-2015 pans are the primary remaining household cookware source of PFOA exposure. If your air fryer or nonstick pan predates 2015 or has visible coating damage, replacing it with a ceramic-coated, stainless steel, or cast iron alternative is the single highest-impact kitchen step for reducing PFAS cancer-relevant exposure at home.
PFAS cancer risk is now firmly established in the scientific literature, particularly for PFOA (IARC Group 1, December 2023) and to a lesser degree PFOS (IARC Group 2B). The cancers with the strongest evidence are kidney cancer (renal cell carcinoma), testicular cancer, and thyroid cancer. Emerging evidence also supports bladder and breast cancer associations.
Kidney cancer: The strongest human evidence. The C8 Science Panel confirmed a probable link from the 69,000-person Parkersburg cohort. NCI PLCO trial data found relative risk approximately 1.9 for higher serum PFOA at population-level exposure. A 2024 county-level US incidence study found PFNA associated with kidney cancer IRR 1.07 (95% CI 1.03-1.11).
Testicular cancer: C8 Science Panel probable link. Studies of military personnel with AFFF exposure show elevated rates. PFAS accumulates in testicular tissue at multiples of blood serum concentration and disrupts testosterone synthesis in Leydig cells.
Thyroid cancer: 2023 Lancet eBioMedicine meta-analysis found 56% increased risk in human cohorts with higher PFAS exposure. PFOA structural mimicry of thyroid hormones provides clear mechanistic basis.
Bladder cancer: 2024 county-level analysis found IRR 1.03-1.08 for multiple PFAS compounds. PFAS concentration in urine provides sustained bladder epithelium contact.
Breast cancer: Emerging evidence for hormone receptor-positive subtype, consistent with PFAS endocrine disruption of estrogen signaling.
Cancer burden estimate: A 2025 study estimated PFAS-contaminated drinking water contributes more than 6,800 new cancer cases per year in the US.
Mechanisms: Oxidative stress, immunosuppression, epigenetic alterations, PPAR-alpha activation, and endocrine disruption - multiple converging carcinogenic pathways documented in both animal models and human studies.
US Federal: PFOA was phased out of US manufacturing under EPA's voluntary PFOA Stewardship Program (2006-2015). In April 2024, EPA finalized Maximum Contaminant Levels of 4 parts per trillion (ppt) for both PFOA and PFOS in public drinking water - with a Maximum Contaminant Level Goal of zero for both compounds, meaning no level is considered safe. Water utility compliance deadline is 2029. In July 2024, PFOA was designated a Superfund hazardous substance under CERCLA, triggering cleanup liability at contaminated sites. PFOS is subject to ongoing regulatory action.
IARC Classification (2023): PFOA classified Group 1 (confirmed human carcinogen). PFOS classified Group 2B (possibly carcinogenic to humans). Published in IARC Monographs Volume 135 (February 2025 full publication).
State Level: Minnesota banned PFAS in nonstick cookware effective January 2025. Colorado followed in January 2026. Maine enacted broad PFAS product bans. Vermont and Connecticut bans take effect in 2028. California Prop 65 lists PFOA as a known carcinogen and reproductive toxicant.
EU: PFOA banned under the EU Persistent Organic Pollutants Regulation since 2020. The EU Universal PFAS Restriction proposal, if adopted, would ban the entire PFAS class across consumer products.
Stockholm Convention (International): PFOA listed as a persistent organic pollutant in 2019, triggering global phase-out obligations for signatory nations. PFOS was listed in 2009.
How to reduce exposure
Prioritize by exposure pathway. Drinking water is the highest-impact target: if you live near known contamination or your tap water tests above EPA MCLs, install an NSF/ANSI 58-certified reverse osmosis system or an NSF 53/P473-certified carbon block filter. Standard pitcher filters do not reliably remove PFAS. Second priority: replace pre-2015 or visibly scratched/worn nonstick cookware and air fryer baskets with ceramic-coated, stainless steel, cast iron, or carbon steel alternatives. Third: reduce fast-food and takeout packaging exposure by cooking at home and choosing fresh foods over microwave packaged foods. For higher-risk individuals near contaminated sites, water testing should come before any other action - contact your county health department or use an NSF-certified lab to test your water.
Who is most at risk
When to seek medical attention
If you have lived near a known PFAS contamination site (PFAS manufacturing plant, military base with AFFF history, or industrial facility), worked as a firefighter or in PFAS-adjacent industry, or received notification that your drinking water has exceeded EPA PFAS MCLs, discuss your exposure history with your doctor. Biomonitoring (blood PFAS testing) is available through some physicians and specialty labs. If you have kidney, testicular, or thyroid cancer in your personal or family history combined with potential high PFAS exposure, this context is relevant for your oncologist. The ATSDR and many state health departments have PFAS clinical guidance resources for healthcare providers.
Common product triggers
Product categories to avoid
Look for these
What this does NOT cover
This entry covers PFAS cancer risk from dietary, water, and household product exposures. It does not address the full scope of PFAS health effects beyond cancer (immune suppression, reproductive effects, thyroid disruption, cholesterol elevation - these are covered in the main PFAS and PFOA entries). It does not address remediation of contaminated sites or industrial cleanup obligations. The cancer risk data described here is primarily derived from PFOA and PFOS - the most studied PFAS. The cancer profiles of replacement PFAS (GenX, PFBS, PFHxA, and hundreds of other compounds) are largely unknown, which is why total PFAS-free verification via total organic fluorine testing matters more than testing for named compounds individually.
How to verify
For water: look up your utility's annual Consumer Confidence Report (utilities are required to publicly disclose PFAS test results) and cross-reference at ewg.org/tapwater. For private wells, have water tested by an NSF-certified laboratory. For cookware and air fryers: contact the manufacturer and ask for third-party test results showing total organic fluorine (TOF) below detectable limits - not just a PFOA-free statement. NSF 537 certification (search at nsf.org) is the most rigorous third-party verification available for cookware. For workplace or community exposure assessment: contact your state health department or the ATSDR (Agency for Toxic Substances and Disease Registry) for community exposure studies and guidance on biomonitoring.
PFOA
PFOS
PFNA
GenX (HFPO-DA)
| State | Status | Effective Date | What Is Banned |
|---|---|---|---|
| Minnesota | |||
| Colorado | |||
| Maine | |||
| Vermont | |||
| Connecticut | |||
| California |
Minnesota
Timeline
What to look for instead
What this means for your family
Every product scored on safety, efficacy, and usability - so you know which products to trust around pfas cancer risk.
Get the Air Fryer shortlist, free
The picks that cleared safety, what to skip, and why price didn’t predict the winner.
No spam. Unsubscribe any time.
As of December 2023, PFOA (perfluorooctanoic acid) is the only PFAS classified as a confirmed Group 1 human carcinogen by IARC - the WHO's cancer research authority. PFOS (perfluorooctanesulfonic acid) was classified Group 2B, meaning it is possibly carcinogenic based on strong mechanistic evidence but currently inadequate direct human data. Many other PFAS have not been evaluated for carcinogenicity at all. This does not mean other PFAS are safe - it means they have not been studied at the same depth as PFOA and PFOS.
Kidney cancer (renal cell carcinoma) and testicular cancer have the strongest and most replicated human evidence, confirmed by the C8 Science Panel's 69,000-person study and multiple independent cohort analyses. Thyroid cancer has emerging evidence with a 56% risk increase found in a 2023 Lancet meta-analysis. Bladder cancer and hormone receptor-positive breast cancer show preliminary associations in recent studies. Liver cancer evidence exists primarily from animal data. The cancer profile for most PFAS beyond PFOA and PFOS is largely unknown.
If your pan was manufactured after 2015 and the coating is intact, the direct PFOA cancer risk is very low - PFOA was phased out of US cookware manufacturing by 2015. The remaining questions are whether it contains GenX (PFOA's replacement, with its own emerging health concerns) or other PFAS. For post-2015 pans with intact coatings, this is a low-priority cancer risk compared to drinking water. If you have pre-2015 pans or any pan with scratched, chipped, or worn coating, replacing it is a higher priority.
Your water utility is required to test for PFAS and disclose results in its annual Consumer Confidence Report. You can also check EWG's Tap Water Database at ewg.org/tapwater by entering your zip code. If you are on a private well near a military base, airport, or chemical facility, you should have your water tested by an NSF-certified lab - your county health department can provide referrals. The EPA's MCL of 4 ppt for PFOA and PFOS is the current regulatory threshold, but with an MCLG of zero, filtering below detectable levels is the most protective approach.
Yes - the right filter can dramatically reduce PFAS in drinking water. NSF/ANSI 58-certified reverse osmosis systems remove 95-99% of PFOA and PFOS. NSF/ANSI 53 or P473-certified activated carbon block filters remove 70-99% of long-chain PFAS including PFOA. Standard pitcher filters (most Brita and PUR products) do not reliably remove PFAS and should not be relied on for PFAS reduction. Verify NSF certification by searching your specific model number at nsf.org and confirming PFOA and PFOS appear on the certified contaminant list.
Children face higher PFAS body burden relative to their size (due to hand-to-mouth behavior, faster metabolic rates, and formula preparation with contaminated water). The immune suppression effect of PFAS is particularly well-documented in children - it reduces vaccine antibody responses. The direct childhood cancer evidence from PFAS is less developed than adult cancer evidence, but a 2025 California study found associations between prenatal PFAS exposure from contaminated water and childhood cancer risk. Developmental timing of exposure may be as important as dose magnitude for long-term cancer outcomes.
Yes, this is a meaningful concern. The Department of Defense has identified 723 installations where PFAS may have been used or released, primarily through AFFF firefighting foam. Studies of military personnel and surrounding communities near AFFF-heavy bases have found elevated PFAS blood levels and, in some populations, elevated cancer rates. If you live near or downwind of a military installation with known AFFF use history, testing your drinking water is a high-priority step. Many states have established testing programs for communities near military bases - your state health department can direct you to available resources.
For post-2015 air fryers with intact PTFE coatings, the direct PFOA cancer risk is very low - PFOA was phased out of PTFE manufacturing by 2015. The higher concern is for pre-2015 air fryers or any unit with worn, scratched, or chipped basket coatings. Air fryers may be a somewhat higher exposure concern than open pans because the enclosed cooking chamber concentrates any particles released from the coating. If your air fryer predates 2015 or has visible coating damage, replacing it with a stainless steel or ceramic basket model is the most straightforward risk reduction step.
Pregnant women and their fetuses. PFAS cross the placenta. While the cancer risk from prenatal exposure is difficult to separate from lifetime exposure, prenatal PFAS exposure has been studied in relation to childhood cancer. A 2025 PMC study on prenatal PFAS exposure from contaminated water in California (2000-2015) found associations with childhood cancer risk. The fetal cancer risk pathway is less well-characterized than adult risks, but the biological plausibility of early-life exposure establishing long-term cancer risk is grounded in the epigenetic alteration evidence.
People with older or damaged nonstick cookware. Pre-2015 nonstick cookware and air fryers with PTFE coatings were manufactured using PFOA. Scratched or worn coatings on older pans are a dietary exposure pathway - studies have measured PFAS migration from worn nonstick surfaces into food at levels that increase significantly with coating damage and with high-heat cooking.
For most Americans who don't live near major industrial contamination sites, drinking water is nonetheless the most important PFAS cancer risk pathway to address.
The EPA's April 2024 final rule set Maximum Contaminant Levels (MCLs) for six PFAS in public drinking water: - PFOA: 4 parts per trillion (ppt) - PFOS: 4 ppt - PFNA: 10 ppt - PFHxS: 10 ppt - HFPO-DA (GenX): 10 ppt - Mixtures of PFNA, PFHxS, PFBS, and HFPO-DA: sum-of-fractions approach
The EPA set the Maximum Contaminant Level Goal (MCLG) for PFOA and PFOS at zero - meaning the agency has determined there is no level considered safe, and the 4 ppt MCL represents the lowest practically enforceable limit, not a safety threshold.
Water utility compliance is not required until 2029. Between now and then, and for private well users permanently, water filters are the practical protection.
Not all filters work: - Reverse osmosis systems (NSF/ANSI 58 certified) remove 95-99% of PFOA and PFOS - Activated carbon block filters (NSF/ANSI 53 or P473 certified) remove long-chain PFAS including PFOA at 70-99% effectiveness - Standard pitcher filters (most Brita and PUR models) do not reliably remove PFAS
For cookware and air fryer risk, the single most actionable fact is the 2015 phase-out date. PFOA was used as a manufacturing processing aid in PTFE (Teflon) production until 2013-2015. Pre-2015 nonstick cookware and air fryers with PTFE baskets may contain residual PFOA in the coating itself.
Post-2015 nonstick cookware should not contain PFOA. However, "PFOA-free" labels tell you only that one specific compound is absent - they say nothing about whether the pan contains GenX (the PFOA replacement), other PFAS, or whether the PTFE polymer itself is a concern under high-heat conditions.
For cancer risk specifically, the most conservative approach is replacing pre-2015 or visibly damaged nonstick cookware with ceramic-coated, stainless steel, cast iron, or carbon steel alternatives - none of which involve PFAS by chemistry.
The cancer risk from PFAS is real and is now confirmed by the highest scientific authority in carcinogen classification. But it is not a reason to panic - it is a reason to be strategic about which exposures you prioritize reducing.
The data consistently points to drinking water as the highest-risk pathway for most families (especially those near contamination sites), followed by older damaged cookware, and then food packaging. Occupational and site-specific exposures are in a different risk category altogether.
For a family with no history of residential or occupational proximity to contaminated sites, the practical agenda is: know your water's PFAS status, filter if needed, replace pre-2015 or worn nonstick cookware, and deprioritize fast-food wrappers and microwave packaging when practical.
The science has moved decisively. PFOA causes cancer in humans. PFOS probably does. The question now is not whether to act, but which actions produce the most exposure reduction per unit of effort and cost - and the answer to that question is increasingly clear.
Watch out for
Effective:
Colorado
Effective:
Maine
Effective:
Vermont
Effective:
Connecticut
Effective:
California
Effective: